Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Jan;77(1):580–583. doi: 10.1073/pnas.77.1.580

Demonstration of a specific mitochondrial isovaleryl-CoA dehydrogenase deficiency in fibroblasts from patients with isovaleric acidemia.

W J Rhead, K Tanaka
PMCID: PMC348317  PMID: 6928646

Abstract

To study the enzymatic basis of isovaleric acidemia, we have developed assay methods for isovaleryl-CoA and butyryl-CoA dehydrogenases that measure the amount of tritium released from the respective [2,3-3H]acyl CoAs. Because assay of these enzymes in human fibroblast homogenates was subject to interference by nonspecific reactions, we have isolated mitochondria from cultured skin fibroblasts by protease treatment, homogenization, and differential centrifugation. By using this assay method with these isolated mitochondria, we have demonstrated a specific deficiency of isovaleryl-CoA dehydrogenase [isovaleryl-CoA: (acceptor) oxidoreductase, EC 1.3.99.10] activity in cultured skin fibroblasts from five patients with isovaleric acidemia. In contrast, mitochondrial butyryl-CoA dehydrogenase [butyryl-CoA: (acceptor) oxidoreductase, EC 1.3.99.2] activity in these cells was preserved at normal levels. These results have been reproduced by using the conventional dye reduction assays. These observations give further support to the hypothesis that isovaleryl CoA is dehydrogenated by a specific enzyme and that isovaleric acidemia is due to a deficiency of this enzyme.

Full text

PDF
580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budd M. A., Tanaka K., Holmes L. B., Efron M. L., Crawford J. D., Isselbacher K. J. Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism. N Engl J Med. 1967 Aug 17;277(7):321–327. doi: 10.1056/NEJM196708172770701. [DOI] [PubMed] [Google Scholar]
  2. Danner D. J., Wheeler F. B., Lemmon S. K., Elsas L. J., 2nd In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate. Pediatr Res. 1978 Mar;12(3):235–238. doi: 10.1203/00006450-197803000-00016. [DOI] [PubMed] [Google Scholar]
  3. Engel P. C. Possibility of inborn defect in isovalericacidaemia involving altered enzyme specificity rather than total inactivity. Nature. 1974 Mar 8;248(5444):140–142. doi: 10.1038/248140a0. [DOI] [PubMed] [Google Scholar]
  4. Hall C. L. Acyl-CoA dehydrogenases and electron-transferring flavoprotein. Methods Enzymol. 1978;53:502–518. doi: 10.1016/s0076-6879(78)53053-x. [DOI] [PubMed] [Google Scholar]
  5. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Lazarow P. B. Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J Biol Chem. 1978 Mar 10;253(5):1522–1528. [PubMed] [Google Scholar]
  8. Loverde A. W., Lehrer G. M. Subcellular distribution of isocitrate dehydrogenases in neonatal and adult mouse brain. J Neurochem. 1973 Feb;20(2):441–448. doi: 10.1111/j.1471-4159.1973.tb12143.x. [DOI] [PubMed] [Google Scholar]
  9. Mahoney M. J., Hart A. C., Steen V. D., Rosenberg L. E. Methylmalonicacidemia: biochemical heterogeneity in defects of 5'-deoxyadenosylcobalamin synthesis. Proc Natl Acad Sci U S A. 1975 Jul;72(7):2799–2803. doi: 10.1073/pnas.72.7.2799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miller W. W., Richards J. H. Mechamism of action of coenzyme B12. Hydrogen transfer in the isomerization of methylmalonyl coenzyme A to succinyl coenzyme A. J Am Chem Soc. 1969 Mar 12;91(6):1498–1507. doi: 10.1021/ja01034a037. [DOI] [PubMed] [Google Scholar]
  11. Millis A. J., Pious D. A. Oxidative phosphorylation in mitochondria isolated from human fibroblasts. Biochim Biophys Acta. 1973 Jan 18;292(1):73–77. doi: 10.1016/0005-2728(73)90251-x. [DOI] [PubMed] [Google Scholar]
  12. Tanaka K., Budd M. A., Efron M. L., Isselbacher K. J. Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci U S A. 1966 Jul;56(1):236–242. doi: 10.1073/pnas.56.1.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tanaka K., Mandell R., Shih V. E. Metabolism of [1-(14)C] and [2-(14)C] leucine in cultured skin fibroblasts from patients with isovaleric acidemia. Characterization of metabolic defects. J Clin Invest. 1976 Jul;58(1):164–172. doi: 10.1172/JCI108446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tanaka K., Orr J. C., Isselbacher K. J. Identification of beta-hydroxyisovaleric acid in the urine of a patient with isovaleric acidemia. Biochim Biophys Acta. 1968 May 1;152(3):638–641. doi: 10.1016/0005-2760(68)90107-0. [DOI] [PubMed] [Google Scholar]
  15. Yagil G., Feldman M. The stability of some enzymes in cultured cells. Exp Cell Res. 1969 Jan;54(1):29–36. doi: 10.1016/0014-4827(69)90288-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES